128 related articles for article (PubMed ID: 25702955)
1. Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy.
Azim HA; Vingiani A; Peccatori F; Viale G; Loi S; Pruneri G
Breast; 2015 Jun; 24(3):290-3. PubMed ID: 25702955
[TBL] [Abstract][Full Text] [Related]
2. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer.
Polónia A; Pinto R; Cameselle-Teijeiro JF; Schmitt FC; Paredes J
J Clin Pathol; 2017 Oct; 70(10):860-867. PubMed ID: 28373294
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitivity, tumor infiltrating lymphocytes (TILs), and survival of postpartum PABC patients treated by neoadjuvant chemotherapy.
Labrosse J; Abdennebi I; Thibault L; Laas E; Merckelbagh H; Morel C; Lam T; Lae M; Reyal F; Hamy AS
Breast; 2018 Dec; 42():61-67. PubMed ID: 30179779
[TBL] [Abstract][Full Text] [Related]
5. Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer.
Luen SJ; Savas P; Fox SB; Salgado R; Loi S
Pathology; 2017 Feb; 49(2):141-155. PubMed ID: 28049579
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles.
Sajjadi E; Venetis K; Noale M; Azim HA; Blundo C; Bonizzi G; Di Loreto E; Scarfone G; Ferrero S; Maggi S; Barberis M; Veronesi P; Galimberti VE; Viale G; Fusco N; Peccatori FA; Guerini-Rocco E
Cells; 2022 Jul; 11(15):. PubMed ID: 35892583
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Infiltrating Lymphocytes in Low-Risk Patients With Breast Cancer Treated With Single-Dose Preoperative Partial Breast Irradiation.
Vasmel JE; Vreuls CPH; Manson QF; Charaghvandi RK; van Gorp J; van Leeuwen AMG; van Diest PJ; Verkooijen HM; van den Bongard HJGD
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1325-1331. PubMed ID: 33333201
[TBL] [Abstract][Full Text] [Related]
8. Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer.
Lee HJ; Park IA; Song IH; Shin SJ; Kim JY; Yu JH; Gong G
J Clin Pathol; 2016 May; 69(5):422-30. PubMed ID: 26475777
[TBL] [Abstract][Full Text] [Related]
9. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.
Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F
Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of B lymphocyte infiltration in breast cancer].
Yu H; Yang J; Jiao S; Wang J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 May; 33(5):750-5. PubMed ID: 23689000
[TBL] [Abstract][Full Text] [Related]
11. Presence of CD3+ tumor infiltrating lymphocytes is significantly associated with good prognosis in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Srivastava AN; Makker A; Goel MM
Indian J Cancer; 2013; 50(3):239-44. PubMed ID: 24061465
[TBL] [Abstract][Full Text] [Related]
12. [Monitoring of anti-tumour cell-mediated response in patients with renal cell carcinoma, disturbance of T cell proliferation].
Lukesová S; Vroblová V; Hlávková D; Kopecký O; Vokurková D; Morávek P; Safránek H; Soucek P
Vnitr Lek; 2008 Feb; 54(2):139-45. PubMed ID: 23687704
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer.
Sheu BC; Kuo WH; Chen RJ; Huang SC; Chang KJ; Chow SN
Breast; 2008 Dec; 17(6):604-10. PubMed ID: 18656354
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab.
Lee HJ; Kim JY; Park IA; Song IH; Yu JH; Ahn JH; Gong G
Am J Clin Pathol; 2015 Aug; 144(2):278-88. PubMed ID: 26185313
[TBL] [Abstract][Full Text] [Related]
15. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
16. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
[TBL] [Abstract][Full Text] [Related]
17. Predictive and prognostic significance of tumor-infiltrating lymphocytes in patients with breast cancer treated with neoadjuvant systemic therapy.
Melichar B; Študentova H; Kalábová H; Vitásková D; Čermáková P; Hornychová H; Ryška A
Anticancer Res; 2014 Mar; 34(3):1115-25. PubMed ID: 24596349
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of T lymphocytes infiltration in breast cancer].
Yu HM; Jiao SC; Yang JL; Wang JD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):199-206. PubMed ID: 23643010
[TBL] [Abstract][Full Text] [Related]
19. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
[TBL] [Abstract][Full Text] [Related]
20. Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists.
Tramm T; Di Caterino T; Jylling AB; Lelkaitis G; Lænkholm AV; Ragó P; Tabor TP; Talman MM; Vouza E;
Acta Oncol; 2018 Jan; 57(1):90-94. PubMed ID: 29168428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
